# FDA Inspection 662416 - SPI Pharma, Inc. - May 12, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-inc/67e19338-d4c6-4076-9160-0d7d2d607a20
Source feed: FDA_Inspections

> FDA Inspection 662416 for SPI Pharma, Inc. on May 12, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 662416
- Company Name: SPI Pharma, Inc.
- Inspection Date: 2010-05-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1291622 - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-inc/91c91461-cf4e-42b3-b879-de55cc40ce0f)
- [FDA Inspection 1291622 - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-inc/eedc8fd1-d70f-4ef3-9b61-24f1f91e81d6)
- [FDA Inspection 1090151 - 2019-04-29](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-inc/25e3df3f-2341-4e01-9ad4-d7554d42a31f)
- [FDA Inspection 1003696 - 2017-03-06](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-inc/5a604014-68e6-4ac9-b44b-2e9b907fd82d)
- [FDA Inspection 860789 - 2013-11-19](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-inc/bbb7ab92-c354-408a-9d9d-c6eef237aea3)

Company: https://www.globalkeysolutions.net/companies/spi-pharma-inc/484ad664-00d6-4107-915e-a68a394e0b55

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c